l6000 (TargetMol)
95
Structured Review
TargetMol
l6000
L6000, supplied by TargetMol, used in various techniques. Bioz Stars score: 95/100, based on 111 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/natural+product+library+l6000/Natural+Product+Library+for+HTS/pmc12869216-104-1-10
Average 95 stars, based on 111 article reviews
L6000, supplied by TargetMol, used in various techniques. Bioz Stars score: 95/100, based on 111 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/natural+product+library+l6000/Natural+Product+Library+for+HTS/pmc12869216-104-1-10
Average 95 stars, based on 111 article reviews
l6000 - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
Expressing:Article Title: FOXO3 upregulates and activates GSDME to trigger myeloma cell pyroptosis Article Snippet: .. HEK293T cells expressing GSDME promoter-driving luciferase was incubated with individual compounds from a Article Title: FOXO3 upregulates and activates GSDME to trigger myeloma cell pyroptosis Article Snippet: .. HEK293T cells expressing GSDME promoter-driving luciferase was incubated with individual compounds from a Luciferase:Article Title: FOXO3 upregulates and activates GSDME to trigger myeloma cell pyroptosis Article Snippet: .. HEK293T cells expressing GSDME promoter-driving luciferase was incubated with individual compounds from a Article Title: FOXO3 upregulates and activates GSDME to trigger myeloma cell pyroptosis Article Snippet: .. HEK293T cells expressing GSDME promoter-driving luciferase was incubated with individual compounds from a Incubation:Article Title: FOXO3 upregulates and activates GSDME to trigger myeloma cell pyroptosis Article Snippet: .. HEK293T cells expressing GSDME promoter-driving luciferase was incubated with individual compounds from a Article Title: FOXO3 upregulates and activates GSDME to trigger myeloma cell pyroptosis Article Snippet: .. HEK293T cells expressing GSDME promoter-driving luciferase was incubated with individual compounds from a Drug discovery:Article Title: High-throughput virtual screening to identify potential small molecule inhibitors of the Zα domain of the adenosine deaminases acting on RNA 1(ADAR1). Article Snippet: Changes in RNA editing are closely associated with diseases such as cancer, viral infections, and autoimmune disorders.. Adenosine deaminase (ADAR1), which acts on RNA 1, plays a key role in adenosine to inosine editing and is a potential therapeutic target for these various diseases.. The p150 subtype of ADAR1 is the only one that contains a Zα domain that binds to both Z-DNA and Z-RNA. |